Previous Article | Next Article ![]()
Journal of Virology, March 1999, p. 2038-2044, Vol. 73, No. 3
Laboratory of Cellular Oncology, National
Cancer Institute, National Institutes of Health, Bethesda, Maryland
20892-4255,1 and
Cancer Research
Institute, Slovak Academy of Sciences, Bratislava,
Slovakia2
Received 23 July 1998/Accepted 20 November 1998
The c-myb oncogene has been a target of retroviral
insertional mutagenesis in murine monocytic leukemias. One mechanism by which c-myb can be activated is through the integration of
a retroviral provirus into the central portion of the locus, causing
premature termination of c-myb transcription and
translation. We had previously shown that a leukemia-specific c-Myb
protein, truncated at the site of proviral integration by 248 amino
acids, had approximately a fourfold-increased half-life compared to the
normal c-Myb protein, due to its ability to escape rapid degradation by
the ubiquitin-26S proteasome pathway. Here we provide evidence for the
existence of more than one instability determinant in the
carboxy-terminal region of the wild-type protein, which appear to act
independently of each other. The data were derived from examination of
premature termination mutants and deletion mutants of the normal
protein, as well as analysis of another carboxy-terminally truncated
protein expressed in leukemia. Evidence is provided that one
instability determinant is located in the terminal 87 amino acids of
the protein and another is located in the vicinity of the internal
region that has leucine zipper homology. In leukemias, different
degrees of protein stability are attained following proviral
integration depending upon how many determinants are removed.
Interestingly, although PEST sequences (rich in proline, glutamine,
serine, and threonine), often associated with degradation, are found in
c-Myb, deletion of PEST-containing regions had no effect on protein
turnover. This study provides further insight into how inappropriate
expression of c-Myb may contribute to leukemogenesis. In addition, it
will facilitate further studies aimed at characterizing the specific role of individual regions of the normal protein in targeting to the
26S proteasome.
0022-538X/99/$00.00+0
Identification of Protein Instability Determinants in the
Carboxy-Terminal Region of c-Myb Removed as a Result of Retroviral
Integration in Murine Monocytic Leukemias
and
*
Corresponding author. Mailing address: Laboratory of
Cellular Oncology, National Cancer Institute, NIH, Building 37, Room 2B04, 37 Convent Dr., Bethesda, MD 20892-4255. Phone: (301) 496-6763. Fax: (301) 402-1031. E-mail: LWOLFF{at}helix.nih.gov.
Present address: Institute of Molecular Biology, Slovak Academy of
Sciences, Bratislava, Slovakia.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|